33514 Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 1, 2022. 

ADDRESSES: DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

submit electronic comments on or 

objections of the requested registration, 

as provided in this notice. This notice 

does not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(API) for product development and 

distribution to DEA registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 

applicable laws, treaties, and 

regulations and to ensure adequate 

safeguards against diversion are in 

place. 

As this applicant has applied to 

become registered as a bulk 

manufacturer of marihuana, the 

application will be evaluated under the 

criteria of 21 U.S.C. 823(a). DEA will 

conduct this evaluation in the manner 

described in the rule published at 85 FR 

82333 on December 18, 2020, and 

reflected in DEA regulations at 21 CFR 

part 1318. 

In accordance with 21 CFR 

1301.33(a), DEA is providing notice that 

on March 16, 2022, Nusachi Labs, LLC, 

2909 Armory Drive, Nashville, 

Tennessee 37204, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substances: 

Controlled substance Drug 

code Schedule 

Marihuana Extract ........... 7350 I 

Marihuana ........................ 7360 I 

Tetrahydrocannabinols .... 7370 I 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11826 Filed 6–1–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–954] 

Bulk Manufacturer of Controlled 

Substances Application: Sigma Aldrich 

Research Biochemicals, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sigma Aldrich Research 

Biochemicals, Inc. has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 1, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 1, 2022. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 29, 2021, 

Sigma Aldrich Research Biochemicals, 

Inc., 400–600 Summit Drive, Burlington, 

Massachusetts 01803, applied to be 

registered as a bulk manufacturer of the 

following basic classes of controlled 

substances: 

Controlled substance Drug code Schedule 

Cathinone ........................................................................................................................................................................ 1235 I 

4-Methyl-N-Methylcathinone ............................................................................................................................................ 1248 I 

Methaqualone .................................................................................................................................................................. 2565 I 

JWH–018 & AM678 ......................................................................................................................................................... 7118 I 

1-(5-Fluoropentyl)-3-(1-Naphthoyl)Indole ........................................................................................................................ 7201 I 

Lysergic Acid Diethylamide ............................................................................................................................................. 7315 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Mescaline ......................................................................................................................................................................... 7381 I 

2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

Alpha-Methyltryptamine ................................................................................................................................................... 7432 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

5-Methoxy-N,N-Diisopropyltryptamine ............................................................................................................................. 7439 I 

1-Benzylpiperazine .......................................................................................................................................................... 7493 I 

2-(2,5-Dimethoxyphenyl)Ethanamine .............................................................................................................................. 7517 I 

3,4-Methylenedioxypyrovalerone ..................................................................................................................................... 7535 I 

3,4-Methylenedioxy-N-Methylcathinone .......................................................................................................................... 7540 I 

Heroin .............................................................................................................................................................................. 9200 I 

Normorphine .................................................................................................................................................................... 9313 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Acetyl Fentanyl ................................................................................................................................................................ 9821 I 

Amphetamine ................................................................................................................................................................... 1100 II 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 33515 

Controlled substance Drug code Schedule 

Methylphenidate .............................................................................................................................................................. 1724 II 

Nabilone ........................................................................................................................................................................... 7379 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

Cocaine ............................................................................................................................................................................ 9041 II 

Codeine ........................................................................................................................................................................... 9050 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Methadone ....................................................................................................................................................................... 9250 II 

Morphine .......................................................................................................................................................................... 9300 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Levo-Alphacetylmethadol (LAAM) ................................................................................................................................... 9648 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

The company plans to manufacture 

reference standards. 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11823 Filed 6–1–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1017] 

Importer of Controlled Substances 

Application: Unither Manufacturing 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Unither Manufacturing LLC 

has applied to be registered as an 

importer of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before July 5, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 5, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on April 8, 2022, Unither 

Manufacturing LLC, 331 Clay Road, 

Rochester, New York 14623–3226, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled 

substance 

Drug 

code Schedule 

Methylphenidate ........... 1724 II 

The company plans to import the 

listed controlled substance solely for 

updated analytical testing purposes for 

European customer requirements. This 

analysis is required to allow the 

company to export domesticallymanufactured finished dosage forms to 

foreign markets. No other activity for 

this drug code is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Kristi O’Malley, 

Assistant Administrator. 

[FR Doc. 2022–11824 Filed 6–1–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1008] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: FPC 

Group LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before August 1, 2022. 

ADDRESSES: DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 


jspears on DSK121TN23PROD with NOTICES1